GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study ...
BRIDGEWATER, N.J., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (HILS) (“Hillstream”), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an ...
MedPage Today on MSN
GLP-1s Tied to Big Survival Advantage in Colon Cancer Patients
An analysis of secondary endpoints showed that GLP-1 agonist users had a significantly lower risk of myocardial or cerebral ...
Inherited mutations in the gene BRCA2 significantly increase the risk of carriers to breast and ovarian cancers. BRCA2, a crucial player in the body's DNA repair system, aids in repairing damaged DNA.
BRIDGEWATER, N.J., April 13, 2023 (GLOBE NEWSWIRE) -- Hillstream BioPharma, Inc. (Nasdaq: HILS) ("Hillstream" or the "Company"), a biotechnology company developing therapeutic candidates targeting ...
In a recent study published in the journal the anti-cancer potential of sRNAs isolated from different mushroom species, researchers in Portugal expanded upon previous studies that demonstrated the ...
In a recent review published in the International Journal of Molecular Sciences, a group of authors investigated and summarized the anti-inflammatory and anti-cancer properties of black garlic (BG), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback